Cytek Biosciences Statistics
Total Valuation
CTKB has a market cap or net worth of $486.87 million. The enterprise value is $252.12 million.
| Market Cap | 486.87M |
| Enterprise Value | 252.12M |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CTKB has 129.14 million shares outstanding. The number of shares has decreased by -1.64% in one year.
| Current Share Class | 129.14M |
| Shares Outstanding | 129.14M |
| Shares Change (YoY) | -1.64% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 8.47% |
| Owned by Institutions (%) | 50.53% |
| Float | 96.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 228.75 |
| PS Ratio | 2.38 |
| Forward PS | 2.30 |
| PB Ratio | 1.49 |
| P/TBV Ratio | 1.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.69, with a Debt / Equity ratio of 0.08.
| Current Ratio | 4.69 |
| Quick Ratio | 3.94 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -98.59 |
Financial Efficiency
Return on equity (ROE) is -20.93% and return on invested capital (ROIC) is -44.57%.
| Return on Equity (ROE) | -20.93% |
| Return on Assets (ROA) | -5.89% |
| Return on Invested Capital (ROIC) | -44.57% |
| Return on Capital Employed (ROCE) | -11.92% |
| Weighted Average Cost of Capital (WACC) | 10.27% |
| Revenue Per Employee | $301,137 |
| Profits Per Employee | -$109,149 |
| Employee Count | 678 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.05 |
Taxes
In the past 12 months, CTKB has paid $38.06 million in taxes.
| Income Tax | 38.06M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.18% in the last 52 weeks. The beta is 1.19, so CTKB's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +18.18% |
| 50-Day Moving Average | 4.24 |
| 200-Day Moving Average | 4.48 |
| Relative Strength Index (RSI) | 40.20 |
| Average Volume (20 Days) | 2,045,421 |
Short Selling Information
The latest short interest is 7.30 million, so 5.66% of the outstanding shares have been sold short.
| Short Interest | 7.30M |
| Short Previous Month | 6.86M |
| Short % of Shares Out | 5.66% |
| Short % of Float | 7.57% |
| Short Ratio (days to cover) | 7.05 |
Income Statement
In the last 12 months, CTKB had revenue of $204.17 million and -$74.00 million in losses. Loss per share was -$0.58.
| Revenue | 204.17M |
| Gross Profit | 105.56M |
| Operating Income | -43.87M |
| Pretax Income | -35.95M |
| Net Income | -74.00M |
| EBITDA | -36.30M |
| EBIT | -43.87M |
| Loss Per Share | -$0.58 |
Balance Sheet
The company has $262.23 million in cash and $27.48 million in debt, with a net cash position of $234.74 million or $1.82 per share.
| Cash & Cash Equivalents | 262.23M |
| Total Debt | 27.48M |
| Net Cash | 234.74M |
| Net Cash Per Share | $1.82 |
| Equity (Book Value) | 327.64M |
| Book Value Per Share | 2.54 |
| Working Capital | 298.37M |
Cash Flow
In the last 12 months, operating cash flow was -$7.30 million and capital expenditures -$5.40 million, giving a free cash flow of -$12.70 million.
| Operating Cash Flow | -7.30M |
| Capital Expenditures | -5.40M |
| Depreciation & Amortization | 7.57M |
| Net Borrowing | 5.86M |
| Free Cash Flow | -12.70M |
| FCF Per Share | -$0.10 |
Margins
Gross margin is 51.70%, with operating and profit margins of -21.49% and -36.25%.
| Gross Margin | 51.70% |
| Operating Margin | -21.49% |
| Pretax Margin | -17.61% |
| Profit Margin | -36.25% |
| EBITDA Margin | -17.78% |
| EBIT Margin | -21.49% |
| FCF Margin | n/a |
Dividends & Yields
CTKB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.64% |
| Shareholder Yield | n/a |
| Earnings Yield | -15.20% |
| FCF Yield | -2.61% |
Analyst Forecast
The average price target for CTKB is $5.69, which is 50.93% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.69 |
| Price Target Difference | 50.93% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 6.82% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTKB has an Altman Z-Score of 3.14 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.14 |
| Piotroski F-Score | 3 |